文献速递甲状腺疾病

DICER1与DGCR8突变型滤泡型甲状腺结节的患病率、分子特征及临床影响

Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

该研究对2家机构的440例滤泡型甲状腺肿瘤进行Sanger测序,发现DICER1和DGCR8热点突变分别占3.2%和1%,突变病例呈现特定miRNA表达谱,DGCR8突变可与RAS突变共存,而DICER1突变病例未发现其他驱动基因事件。

要点

  • 滤泡型甲状腺肿瘤中DICER1和DGCR8热点突变分别占3.2%和1%。
  • DICER1/DGCR8突变病例呈现独特的miRNA失调模式。
  • DGCR8突变可与RAS突变共存,DICER1突变病例无其他驱动基因事件。

核心结论

  • DICER1和DGCR8热点突变在未选择的滤泡型甲状腺肿瘤队列中罕见,突变病例呈现特定miRNA谱。
  • DGCR8突变可与已知RAS基因改变共存,而DICER1突变病例未发现其他驱动基因事件。

研究设计与样本

  • 研究纳入2家机构的440例滤泡型甲状腺肿瘤,采用Sanger测序检测DICER1、DGCR8和RAS家族热点突变,并对DICER1/DGCR8突变病例进行全外显子组测序。
  • 部分病例进行miRNA表达谱分析,关键失调miRNA通过定量RT-PCR验证,并查询TCGA数据库中的DICER1/DGCR8突变和miRNA失调。

主要发现

  • 联合队列中14例(3.2%)滤泡型甲状腺肿瘤携带DICER1热点突变,4例(1%)携带DGCR8热点突变。
  • 有正常组织可用的病例中未发现胚系变异。
  • 2例DGCR8突变病例同时携带致癌性RAS突变。
  • 全外显子组测序未在DICER1/DGCR8阳性病例中发现其他驱动基因事件。
  • 与野生型病变相比,DICER1/DGCR8突变病例呈现独特的miRNA失调模式,且DICER1突变病例显示5‘臂miRNA显著减少,该发现在TCGA队列中得到印证。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mutations in micro-RNA (miRNA) regulators DICER1 and DGCR8 have recently been uncovered, revealing a potential novel mechanism driving thyroid tumor development. However, the true frequency of these hotspot mutations in follicular-patterned thyroid tumors (FTs) and their relation to established driver gene events remain elusive. METHODS: A total of 440 FTs from 2 institutions were interrogated for DICER1, DGCR8, and RAS family hotspot mutations using Sanger sequencing. Whole-exome sequencing was also performed to identify additional driver gene aberrations in DICER1/DGCR8-mutant cases. Subsets of cases were further analyzed using miRNA expression profiling, and key dysregulated miRNAs were validated as markers of DICER1 mutations using quantitative RT-PCR analysis. The Cancer Genome Atlas (TCGA) database was also probed for DICER1/DGCR8 mutations and miRNA dysregulation. RESULTS: Fourteen (3.2%) and 4 (1%) FTs harbored DICER1 and DGCR8 hotspot mutations, respectively, in the combined cohort, and no cases with normal tissue available were found to exhibit a constitutional variant. Two DGCR8-mutant cases also harbored oncogenic RAS mutations. Whole-exome sequencing analysis did not identify additional driver gene events in DICER1/DGCR8-positive cases. Comprehensive miRNA expression profiling revealed a unique pattern of dysregulated miRNAs in DICER1/DGCR8-mutant cases compared with wild-type lesions. Moreover, DICER1-mutant cases showed a remarkable reduction of 5' arm miRNAs, findings corroborated in the TCGA cohort. CONCLUSION: DICER1 and DGCR8 hotspot mutations are rare in unselected cohorts of FTs, and mutated cases exhibit a specific miRNA profile. Although DGCR8 mutations may coexist with established RAS gene alterations, FTs with DICER1 variants were devoid of other driver gene events.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Condello V, Poma AM, Macerola E, et al. Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules. J Clin Endocrinol Metab. 2024. PMID: 38252873. doi:10.1210/clinem/dgae034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。